Early studies reported that BMSCs from lupus patients, compared to matched controls, had a flattened morphology, proliferated more slowly, showed increased ROS, had increased expression of p16INK4a and increased activation of the p53/p21 pathway [74]. Here, CDKN2A is linked to systemic lupus erythematosus.